Article

Mediterranean Diets to Prevent Cardiovascular Outcomes

Author(s):

Nutritional experts have consistently recommended a Mediterranean dietary pattern to aid in preventing chronic disease.

Nutritional experts have consistently recommended a Mediterranean dietary pattern to aid in preventing chronic disease.

At the American College of Cardiology (ACC) 64th Scientific Sessions, Thaminda Liyanage, MBBS shared data from the recent research he and his colleagues conducted to identify the most likely effects Mediterranean diet would have on vascular disease and mortality.

The team gathered combed through MEDLINE, EMBASE, and the Cochrane Central Register to search for randomized controlled trials comparing Mediterranean to control diets.

Additionally, they gathered data on study design, patient characteristics, interventions, follow-up duration, outcomes, and adverse events.

The team included 6 studies with a total of 10,950 participants, reporting the effects on major vascular events), death, and vascular deaths for 3, 5, and 4 studies respectively. For one large study (n=1000) there were serious concerns about the integrity of the data.

Combining data for all the studies, researchers noted there was evidence of protection against major vascular events (RR 0.50, 95% confidence interval 0.29-0.87), coronary events (0.60, 0.37-0.98), stroke (0.65, 0.48-0.89) and heart failure (0.30, 0.17-0.56), but not for all-cause mortality (0.85, 0.61-1.19) or cardiovascular mortality (0.72, 0.42-1.24).

Apparently positive findings for coronary events (0.56, 0.20-1.60), heart failure (0.25, 0.05-1.17) and stroke (0.64, 0.34-1.20) also disappeared when the study of concern was excluded. Also, they did not detect any publication bias on Begg’s test (P=0.33) or Egger’s test (P=0.09).

Ultimately, the study results had concluded, “The Mediterranean diet may protect against vascular disease. However, both the quantity and quality of the available evidence is limited, and there is much greater uncertainty than is widely understood.”

Related Videos
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
© 2024 MJH Life Sciences

All rights reserved.